BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 7642860)

  • 1. Baseline and 6-month costs of primary angioplasty therapy for acute myocardial infarction: results from the primary angioplasty registry.
    Mark DB; O'Neill WW; Brodie B; Ivanhoe R; Knopf W; Taylor G; O'Keefe JH; Grines CL; Davidson-Ray L; Knight JD
    J Am Coll Cardiol; 1995 Sep; 26(3):688-95. PubMed ID: 7642860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease. Results from the Emory Angioplasty Versus Surgery Trial (EAST).
    Weintraub WS; Mauldin PD; Becker E; Kosinski AS; King SB
    Circulation; 1995 Nov; 92(10):2831-40. PubMed ID: 7586249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year clinical outcomes and relative costs of primary infarct artery stenting versus angioplasty following systemic thrombolysis for acute myocardial infarction.
    Rocha-Singh KJ; McShane KJ; Ligon R; Sung CH
    Catheter Cardiovasc Interv; 2000 Feb; 49(2):135-41. PubMed ID: 10642759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and long-term cost implications of coronary stenting.
    Peterson ED; Cowper PA; DeLong ER; Zidar JP; Stack RS; Mark DB
    J Am Coll Cardiol; 1999 May; 33(6):1610-8. PubMed ID: 10334432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Care of acute myocardial infarction by noninvasive and invasive cardiologists: procedure use, cost and outcome.
    Di Salvo TT; Paul SD; Lloyd-Jones D; Smith AJ; Villarreal-Levy G; Bamezai V; Hussain SI; Eagle KA; O'Gara PT
    J Am Coll Cardiol; 1996 Feb; 27(2):262-9. PubMed ID: 8557892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and angiographic outcomes in patients with previous coronary artery bypass graft surgery treated with primary balloon angioplasty for acute myocardial infarction. Second Primary Angioplasty in Myocardial Infarction Trial (PAMI-2) Investigators.
    Stone GW; Brodie BR; Griffin JJ; Grines L; Boura J; O'Neill WW; Grines CL
    J Am Coll Cardiol; 2000 Mar; 35(3):605-11. PubMed ID: 10716461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical predictors easily obtained at presentation predict resource utilization in unstable angina.
    Calvin JE; Klein LW; VandenBerg BJ; Meyer P; Ramirez-Morgen LM; Parrillo JE
    Am Heart J; 1998 Sep; 136(3):373-81. PubMed ID: 9736126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial infarction following coronary artery bypass graft surgery increases healthcare resource utilization.
    Chen JC; Kaul P; Levy JH; Haverich A; Menasché P; Smith PK; Carrier M; Verrier ED; Van de Werf F; Burge R; Finnegan P; Mark DB; Shernan SK;
    Crit Care Med; 2007 May; 35(5):1296-301. PubMed ID: 17414091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?
    O'Brien BJ; Willan A; Blackhouse G; Goeree R; Cohen M; Goodman S
    Am Heart J; 2000 Mar; 139(3):423-9. PubMed ID: 10689256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants.
    Becker RC; Burns M; Gore JM; Spencer FA; Ball SP; French W; Lambrew C; Bowlby L; Hilbe J; Rogers WJ
    Am Heart J; 1998 May; 135(5 Pt 1):786-96. PubMed ID: 9588407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health and cost consequences of early versus late invasive strategy after thrombolysis for acute myocardial infarction.
    Bøhmer E; Kristiansen IS; Arnesen H; Halvorsen S
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):717-23. PubMed ID: 21450598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic analysis of the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT-3) study: costs of reperfusion strategies in acute myocardial infarction.
    Kaul P; Armstrong PW; Cowper PA; Eisenstein EL; Granger CB; Van de Werf F; Mark DB
    Am Heart J; 2005 Apr; 149(4):637-44. PubMed ID: 15990746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates of the initial and long-term cost of coronary bypass surgery and coronary angioplasty.
    Hlatky MA; Boothroyd DB; Brooks MM; Winston C; Rosen A; Rogers WJ; Reeder GS; Smith HC; Ryan TJ; Pitt B; Whitlow PL; Wiens RD; Mark DB
    Am Heart J; 1999 Aug; 138(2 Pt 1):376-83. PubMed ID: 10426855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the relative costs and effectiveness of primary angioplasty versus tissue-type plasminogen activator: the Primary Angioplasty in Myocardial Infarction (PAMI) trial. The PAMI Trial Investigators.
    Stone GW; Grines CL; Rothbaum D; Browne KF; O'Keefe J; Overlie PA; Donohue BC; Chelliah N; Vlietstra R; Catlin T; O'Neill WW
    J Am Coll Cardiol; 1997 Apr; 29(5):901-7. PubMed ID: 9120173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.
    Every NR; Parsons LS; Hlatky M; Martin JS; Weaver WD
    N Engl J Med; 1996 Oct; 335(17):1253-60. PubMed ID: 8857004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcome of myocardial infarction in hospitals with and without invasive capability. Investigators in the National Registry of Myocardial Infarction.
    Rogers WJ; Canto JG; Barron HV; Boscarino JA; Shoultz DA; Every NR
    J Am Coll Cardiol; 2000 Feb; 35(2):371-9. PubMed ID: 10676683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease (ERACI): in-hospital results and 1-year follow-up. ERACI Group.
    Rodriguez A; Boullon F; Perez-Baliño N; Paviotti C; Liprandi MI; Palacios IF
    J Am Coll Cardiol; 1993 Oct; 22(4):1060-7. PubMed ID: 8409041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators.
    Hlatky MA; Rogers WJ; Johnstone I; Boothroyd D; Brooks MM; Pitt B; Reeder G; Ryan T; Smith H; Whitlow P; Wiens R; Mark DB
    N Engl J Med; 1997 Jan; 336(2):92-9. PubMed ID: 8988886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of event and procedure rates following percutaneous transluminal coronary angioplasty in patients with and without previous coronary artery bypass graft surgery [the ROSETTA (Routine versus Selective Exercise Treadmill Testing after Angioplasty) Registry].
    Garzon P; Sheppard R; Eisenberg MJ; Schechter D; Lefkovits J; Goudreau E; Mak KH; Brown DL;
    Am J Cardiol; 2002 Feb; 89(3):251-6. PubMed ID: 11809424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One-year results of the Thrombolysis in Myocardial Infarction (TIMI) IIIB clinical trial. A randomized comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave myocardial infarction.
    Anderson HV; Cannon CP; Stone PH; Williams DO; McCabe CH; Knatterud GL; Thompson B; Willerson JT; Braunwald E
    J Am Coll Cardiol; 1995 Dec; 26(7):1643-50. PubMed ID: 7594098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.